<?xml version="1.0" encoding="UTF-8"?>
<document id="30548441">
	<sentence id="s1" text="Surgical tumor specimens were collected for immunohistochemical staining to evaluate B7-H5 expression.">
		<entity id="s1.e1" charOffset="9-14"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="85-87"
			type="GENE" text="B7" ontology_id="10233"/>
		<entity id="s1.e3" charOffset="88-90"
			type="GENE" text="H5" ontology_id="2260"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e3" pgr="true"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Patients' baseline characteristics, including gender, age, tumor size, tumor location, tumor grading, clinical TNM staging, tumor infiltrating lymphocytes, CA19-9 and chemotherapy treatment, along with the subsequent follow-up data, were documented and analyzed.">
		<entity id="s2.e1" charOffset="59-64"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s2.e2" charOffset="111-114"
			type="GENE" text="TNM" ontology_id="10178"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="When co-cultured with T cells, pancreatic cancer PC cells with high B7-H5 expression induced a more potent immune reaction, indicated by elevated cytokine release and increased proliferation of T lymphocytes compared with cells exhibiting low B7-H5 expression.">
		<entity id="s3.e1" charOffset="42-48"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s3.e2" charOffset="68-70"
			type="GENE" text="B7" ontology_id="10233"/>
		<entity id="s3.e3" charOffset="71-73"
			type="GENE" text="H5" ontology_id="2260"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e3" pgr="true"/>
		<pair id="s3.p2" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Xenograft pancreatic tumors derived from high B7-H5 expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.">
		<entity id="s4.e1" charOffset="21-26"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s4.e2" charOffset="46-48"
			type="GENE" text="B7" ontology_id="10233"/>
		<entity id="s4.e3" charOffset="49-51"
			type="GENE" text="H5" ontology_id="2260"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e3" pgr="true"/>
		<pair id="s4.p2" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
	</sentence>
	<sentence id="s5" text="Of the 136 PDAC tumor tissues, 93 (68.38%) were strong and 43 (31.62%) were weak B7-H5 expression.">
		<entity id="s5.e1" charOffset="16-21"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s5.e2" charOffset="81-83"
			type="GENE" text="B7" ontology_id="10233"/>
		<entity id="s5.e3" charOffset="84-86"
			type="GENE" text="H5" ontology_id="2260"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e3" pgr="true"/>
		<pair id="s5.p2" e1="s5.e1"
		    e2="s5.e2" pgr="false"/>
	</sentence>
	<sentence id="s6" text="TNM staging, tumor location and subsequent chemotherapy were also prognostic factors in these patients.">
		<entity id="s6.e1" charOffset="0-3"
			type="GENE" text="TNM" ontology_id="10178"/>
		<entity id="s6.e2" charOffset="13-18"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s6.p1" e1="s6.e1"
		    e2="s6.e2" pgr="false"/>
	</sentence>
</document>
